Preclinical testing of oncolytic adenovirus sensitivity in patient-derived tumor organoids

Patient-derived organoids (PDOs) have shown the potential to reflect patient sensitivity to chemotherapeutic or targeted drugs. Recently, we showed that organoid models can also serve as a platform to screen for selectivity and potency of oncolytic adenoviruses (OAds). In this protocol, we describe...

Descripción completa

Detalles Bibliográficos
Autores principales: Pascual-Sabater, Silvia, Raimondi, Giulia, Mato-Berciano, Ana, Vaquero, Eva C., Ausania, Fabio, Fillat, Cristina
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2021
Materias:
Protocol
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8672098/
https://www.ncbi.nlm.nih.gov/pubmed/34950892
http://dx.doi.org/10.1016/j.xpro.2021.101017

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8672098/
https://www.ncbi.nlm.nih.gov/pubmed/34950892
http://dx.doi.org/10.1016/j.xpro.2021.101017

Ejemplares similares